Lance K. Heilbrun

Also affiliated with The Barbara Ann Karmanos Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer”.

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer

JAMA Network Open(2021)10.1001/jamanetworkopen.2020.34633

N/A

2.0DataRank · unranked

43 citations

Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde, Clara Hwang +10 more

Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.024

N/A

0.405DataRank · unranked

7 citations

Lance K. Heilbrun, Nitin Vaishampayan, Felicity W. K. Harper, Dongping Shi, Daryn Smith +10 more

A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer

Advances in Radiation Oncology(2021)10.1016/j.adro.2021.100679

N/A

0DataRank · unranked

12 citations

Lance K. Heilbrun, Jordan Maier, Kiran Devisetty, Irene Connolly, Isaac Kaufman +7 more